市場調査レポート

商品コード

1751229

STD診断の市場規模、シェア、動向分析レポート：用途別、製品別、技術別、検査場所別、地域別、セグメント予測、2025年～2030年

STD Diagnostics Market Size, Share & Trends Analysis Report By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Product, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2025年05月05日
発行: Grand View Research
ページ情報: 英文 156 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 5,950 877,625円

レポートPDF及びExcelを1名様のみがご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷はできません。

Printable PDF & Excel (5-User License)

USD 6,950 1,025,125円

レポートPDF及びExcelを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。

Printable PDF & Excel (Enterprise License)

USD 8,950 1,320,125円

レポートの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF及びExcelのテキスト等のコピー＆ペースト、印刷は可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.50円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

STD診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のSTD診断市場規模は2030年までに160億8,000万米ドルに達し、2025年から2030年にかけてCAGR 7.1％で拡大すると推定されています。

性感染症（STD）の疾病負担の増加や、若年層の認知度を高め定期的なスクリーニングを奨励する政府・非営利団体の取り組みが、市場成長を増大させる主な要因です。WHOのデータによると、梅毒、淋病、クラミジア、トリコモナスなどの新規感染者は、世界で毎年約3億7,400万人に上ります。

次世代HIV検査キットやマルチプレックスPCR製品などの先進的な製品の開発・商品化により、医師は様々なSTIをタイムリーに診断・鑑別し、適切な治療を行うことができます。韓国を拠点とする診断会社Seegene, Inc.は、様々な原因物質を検出するAllplex、Anyplex、Seeplex製品の幅広いポートフォリオを提供しています。例えば、Allplex STI/BV Panel Assayは1回の検査で28の原因物質を区別できます。2022年4月、Seegene, Inc.はAllplex HPV HR Detectionの開発を発表しました。

Allplex HPV HR Detectionは、世界で初めて商業化された「3 Ct」PCRアッセイです。Seegene社は、この技術をSTI、尿路感染症（UTI）、呼吸器ウイルス（RV）アッセイを含む製品チェーン全体に応用することに注力しています。この戦略的な技術的進歩は、性感染症（STD）診断薬業界における同社のシェアを拡大する上で、さらなる優位性をもたらすものと期待されます。

HIV国家戦略計画は、2030年までに米国におけるヒト免疫不全ウイルスの流行をなくすためのロードマップです。2021年から2025年まで続くこのHIV計画は、同国にとって3回目の5カ年HIV国家計画であり、2030年までにヒト免疫不全ウイルスの新規感染を90％半減させるという10年目標を掲げています。さらに、「ウイルス性肝炎国家戦略計画」では、性行為によって感染するB型肝炎とC型肝炎に焦点を当てています。2021年1月、米国保健社会福祉省（HHS）は、米国におけるウイルス性肝炎がもたらす予防可能で実質的な公衆衛生の脅威に対処するための全国戦略を発表しました。政府の有益な行動は、STD診断薬産業の拡大に有利な雰囲気を作り出しています。

各社は、新製品の開発や規制当局の承認を支援し、STD診断薬の製品ポートフォリオを強化する戦略的な取り組みを行っています。例えば、2020年8月、DiaSorin, Inc.はLIAISON XL MUREX anti-HBeの導入について米国FDAから510（k）承認を取得しました。これはHBV感染の診断に使用されます。このイムノアッセイ製品は化学発光の原理で作動します。

STD診断市場レポートハイライト

消耗品セグメントは2024年の収益シェア70.01%で市場を独占し、STD診断のための高い検査率と複数のアッセイの商業化により、予測期間中最も速いCAGRで成長すると予測されます。
技術別では、ハイスループットPCR技術の利用が増加していること、HIV検査にNAAT検査が推奨されていることから、分子診断セグメントは予測期間中に最も速いCAGRで成長すると予測されます。複数の病原体を同時に検出するマルチプレックスPCR検査の開発も、STD診断薬業界の成長に寄与すると予想されます。
用途別では、HIV検査分野が2024年にSTD診断薬業界を支配すると予想されます。これは、HIVの高い罹患率、分子検査に対する製品承認の増加、政府の有利な取り組みなどの要因によるものです。
アジア太平洋諸国は、STD検査率の上昇、可処分所得の増加、新興諸国におけるSTD有病率の高さなどから、予測期間中に最も急成長すると予測されます。

セグメントダッシュボード
STD診断市場：用途変動分析、2024年および2030年
CT/NG検査
梅毒検査
- PCR検査
- 非PCR検査
淋病検査
HSV検査
- PCR検査
- 非PCR検査
HPV検査
HIV検査
ウレアプラズマとマイコプラズマの検査
トリコモナス
VZV検査
- PCR検査
- 非PCR検査

第6章 STD診断市場：技術推定・動向分析

セグメントダッシュボード
STD診断市場：技術変動分析、2024年および2030年
免疫測定
分子診断
その他

第7章性感染症診断市場：検査場所の推定・動向分析

セグメントダッシュボード
STD診断市場：検査変動分析、2024年および2030年
商業/民間ラボ
公衆衛生研究所

第8章性感染症診断市場：地域別推定・動向分析

STD診断市場シェア（地域別、2024年および2030年）
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

主要市場参入企業による最近の動向と影響分析
企業分類
企業ヒートマップ分析
企業プロファイル
- BD
- F. Hoffmann-La Roche Ltd
- Hologic Inc.
- Abbott
- Cepheid（Danaher）
- Qiagen
- OraSure Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- Thermo Fisher Scientific, Inc.
- Seegene Inc.
- DiaSorin SpA

図表

List of Tables

Table 1 List of abbreviation
Table 2 Global STD diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 Global STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 4 Global STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 5 Global STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 6 Global STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 7 North America STD diagnostics market, by country, 2018 - 2030 (USD Million)
Table 8 North America STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 9 North America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 10 North America STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 11 North America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 12 U.S. STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 14 U.S. STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 16 Canada STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Canada STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 18 Canada STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 19 Canada STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 20 Mexico STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 21 Mexico STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Mexico STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Mexico STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 24 Europe STD diagnostics market, by country, 2018 - 2030 (USD Million)
Table 25 Europe STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 26 Europe STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 27 Europe STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 28 Europe STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 29 UK STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 UK STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 UK STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 32 UK STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 33 Germany STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 Germany STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35 Germany STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 36 Germany STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 37 France STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 France STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39 France STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 40 France STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 41 Italy STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Italy STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Italy STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 44 Italy STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 45 Spain STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Spain STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47 Spain STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 48 Spain STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 49 Denmark STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 51 Denmark STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 52 Denmark STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 53 Sweden STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Sweden STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 55 Sweden STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 56 Sweden STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 57 Norway STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 58 Norway STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 59 Norway STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 Norway STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 61 Asia Pacific STD diagnostics market, by country, 2018 - 2030 (USD Million)
Table 62 Asia Pacific STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 63 Asia Pacific STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 64 Asia Pacific STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 66 Japan STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 67 Japan STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 68 Japan STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 69 Japan STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 70 China STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 China STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 72 China STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 73 China STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 74 India STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 75 India STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 76 India STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 77 India STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 78 Australia STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 79 Australia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 80 Australia STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 81 Australia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 82 South Korea STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 83 South Korea STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 84 South Korea STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 85 South Korea STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 86 Thailand STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 87 Thailand STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 88 Thailand STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Thailand STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 90 Latin America STD diagnostics market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 92 Latin America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 93 Latin America STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 94 Latin America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 95 Brazil STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 96 Brazil STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 97 Brazil STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 98 Brazil STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 99 Argentina STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 100 Argentina STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 101 Argentina STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 103 MEA STD diagnostics market, by country, 2018 - 2030 (USD Million)
Table 104 MEA STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 105 MEA STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 106 MEA STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 107 MEA STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 108 South Africa STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 110 South Africa STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 116 UAE STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 117 UAE STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 118 UAE STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 119 UAE STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
Table 120 Kuwait STD diagnostics market, by product, 2018 - 2030 (USD Million)
Table 121 Kuwait STD diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 122 Kuwait STD diagnostics market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 STD Diagnostics Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Penetration and growth prospect mapping
Fig. 11 User perspective analysis
Fig. 12 STD Diagnostics Market driver impact
Fig. 13 Prevalence of STIs by WHO regions (in 2023)
Fig. 14 STD Diagnostics Market restraint impact
Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 16 Porter's Five Forces Analysis
Fig. 17 STD diagnostics product outlook: Key takeaways
Fig. 18 STD Diagnostics Market: Product movement analysis
Fig. 19 Instruments and Services market, 2018 - 2030 (USD Million)
Fig. 20 Consumables market, 2018 - 2030 (USD Million)
Fig. 21 Software market, 2018 - 2030 (USD Million)
Fig. 22 STD diagnostics application outlook: Key takeaways
Fig. 23 STD Diagnostics Market: Application movement analysis
Fig. 24 CT/NG testing market, 2018 - 2030 (USD Million)
Fig. 25 Prevalence (%) of syphilis by WHO regions
Fig. 26 Syphilis testing market, 2018 - 2030 (USD Million)
Fig. 27 Syphilis PCR testing market, 2018 - 2030 (USD Million)
Fig. 28 Syphilis non-PCR testing market, 2018 - 2030 (USD Million)
Fig. 29 HSV testing market, 2018 - 2030 (USD Million)
Fig. 30 Herpes Simplex Virus PCR testing market, 2018 - 2030 (USD Million)
Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018 - 2030 (USD Million)
Fig. 32 HPV testing market, 2018 - 2030 (USD Million)
Fig. 33 Prevalence (%) of HIV by WHO regions
Fig. 34 HIV testing market, 2018 - 2030 (USD Million)
Fig. 35 Ureaplasma & mycoplasma testing market, 2018 - 2030 (USD Million)
Fig. 36 Trichomonas testing market, 2018 - 2030 (USD Million)
Fig. 37 VZV testing market, 2018 - 2030 (USD Million)
Fig. 38 VZV PCR testing market, 2018 - 2030 (USD Million)
Fig. 39 VZV non-PCR testing market, 2018 - 2030 (USD Million)
Fig. 40 Other testing market, 2018 - 2030 (USD Million)
Fig. 41 STD diagnostics technology outlook: Key takeaways
Fig. 42 STD Diagnostics Market: Technology movement analysis
Fig. 43 Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig. 44 Immunoassay market, 2018 - 2030 (USD Million)
Fig. 45 Others market, 2018 - 2030 (USD Million)
Fig. 46 STD diagnostics location of testing outlook: Key takeaways
Fig. 47 STD Diagnostics Market: Location of testing movement analysis
Fig. 48 Laboratory testing market, 2018 - 2030 (USD Million)
Fig. 49 Commercial/private labs market, 2018 - 2030 (USD Million)
Fig. 50 Public health labs market, 2018 - 2030 (USD Million)
Fig. 51 Point of care testing market, 2018 - 2030 (USD Million)
Fig. 52 Regional outlook, 2023 & 2030
Fig. 53 Regional marketplace: Key takeaways
Fig. 54 North America SWOT
Fig. 55 North America STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 56 U.S. Country Dynamics
Fig. 57 U.S. Target Disease Prevalence
Fig. 58 U.S. STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 59 Canada Country Dynamics
Fig. 60 Canada Target Disease Prevalence
Fig. 61 Canada STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 61 Mexico Target Disease Prevalence
Fig. 62 Mexico STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 62 Europe SWOT
Fig. 63 Europe STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 64 UK Country Dynamics
Fig. 65 UK Target Disease Prevalence
Fig. 66 UK STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 67 Germany Country Dynamics
Fig. 68 Germany Target Disease Prevalence
Fig. 69 Germany STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 70 France Country Dynamics
Fig. 71 France Target Disease Prevalence
Fig. 72 France STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 73 Spain Country Dynamics
Fig. 74 Spain Target Disease Prevalence
Fig. 75 Spain STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 76 Italy Country Dynamics
Fig. 77 Italy Target Disease Prevalence
Fig. 78 Italy STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 79 Denmark Country Dynamics
Fig. 80 Denmark Target Disease Prevalence
Fig. 81 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 82 Sweden Country Dynamics
Fig. 83 Sweden Target Disease Prevalence
Fig. 84 Sweden STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 85 Denmark Country Dynamics
Fig. 86 Denmark Target Disease Prevalence
Fig. 87 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 88 Asia Pacific SWOT
Fig. 89 Asia Pacific STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 90 Japan Country Dynamics
Fig. 91 Japan Target Disease Prevalence
Fig. 92 Japan STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 93 China Country Dynamics
Fig. 94 China Target Disease Prevalence
Fig. 95 China STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 96 India Country Dynamics
Fig. 97 India Target Disease Prevalence
Fig. 98 India STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 99 Australia Country Dynamics
Fig. 100 Australia Target Disease Prevalence
Fig. 101 Australia STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 102 South Korea Country Dynamics
Fig. 103 South Korea Target Disease Prevalence
Fig. 104 South Korea STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 105 Thailand Country Dynamics
Fig. 106 Thailand Target Disease Prevalence
Fig. 107 Thailand STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 108 Latin America SWOT
Fig. 109 Latin America STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 110 Brazil Country Dynamics
Fig. 111 Brazil Target Disease Prevalence
Fig. 112 Brazil STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 113 Mexico Country Dynamics
Fig. 116 Argentina Country Dynamics
Fig. 117 Argentina Target Disease Prevalence
Fig. 118 Argentina STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 119 Middle East & Africa SWOT
Fig. 120 Middle East & Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 121 South Africa Country Dynamics
Fig. 122 South Africa Target Disease Prevalence
Fig. 123 South Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 124 Saudi Arabia Country Dynamics
Fig. 125 Saudi Arabia Target Disease Prevalence
Fig. 126 Saudi Arabia STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 127 UAE Country Dynamics
Fig. 128 UAE Target Disease Prevalence
Fig. 129 UAE STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 130 Kuwait Country Dynamics
Fig. 131 Kuwait Target Disease Prevalence
Fig. 132 Kuwait STD Diagnostics Market, 2018 - 2030 (USD Million)
Fig. 133 Heat map analysis
Fig. 134 Company market share analysis (2024)
Fig. 135 Company market position analysis (2024)
Fig. 136 Company market position analysis (2024)
Fig. 137 Market differentiators
Fig. 138 Regional Network Map

Product Code: 978-1-68038-686-8

STD Diagnostics Market Growth & Trends:

The global STD diagnostics market size is estimated to reach USD 16.08 billion by 2030, expanding at a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world's first commercialized '3 Ct' PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights:

The consumables segment dominated the market in 2024 with a revenue share of 70.01% and is anticipated to grow at the fastest CAGR over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2024, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. STD Diagnostics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. STD Diagnostics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. STD Diagnostics Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. STD Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Instruments and Services
- 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Consumables
- 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Software
- 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. STD Diagnostics Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. STD Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
5.3. CT/NG testing
- 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Syphilis testing
- 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. PCR testing
  - 5.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Non-PCR testing
  - 5.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Gonorrhea testing
- 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. HSV testing
- 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.2. PCR testing
  - 5.6.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.3. Non-PCR testing
  - 5.6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. HPV testing
- 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. HIV testing
- 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Ureaplasma & Mycoplasma testing
- 5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Trichomonas
- 5.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. VZV testing
- 5.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.11.2. PCR testing
  - 5.11.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.11.3. Non-PCR testing
  - 5.11.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. STD Diagnostics Market: Technology Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. STD Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
6.3. Immunoassay
- 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Molecular Diagnostics
- 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Other
- 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. STD Diagnostics Market: Location of Testing Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. STD Diagnostics Market: Location of Testing Movement Analysis, 2024 & 2030 (USD Million)
7.3. Commercial/Private labs
- 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Public Health Labs
- 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. STD Diagnostics Market: Regional Estimates & Trend Analysis

8.1. STD Diagnostics Market Share, By Region, 2024 & 2030, USD Million
8.2. North America
- 8.2.1. North America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
  - 8.2.2.1. U.S. STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
  - 8.2.3.1. Canada STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
  - 8.2.4.1. Mexico STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
- 8.3.1. Europe STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
  - 8.3.2.1. UK STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
  - 8.3.3.1. Germany STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. France
  - 8.3.4.1. France STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Italy
  - 8.3.5.1. Italy STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Spain
  - 8.3.6.1. Spain STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Denmark
  - 8.3.7.1. Denmark STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Sweden
  - 8.3.8.1. Sweden STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.9. Norway
  - 8.3.9.1. Norway STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
- 8.4.1. Asia Pacific STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Japan
  - 8.4.2.1. Japan STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. China
  - 8.4.3.1. China STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
  - 8.4.4.1. India STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Australia
  - 8.4.5.1. Australia STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. South Korea
  - 8.4.6.1. South Korea STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
  - 8.4.7.1. Thailand STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
- 8.5.1. Latin America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
  - 8.5.2.1. Brazil STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
  - 8.5.3.1. Argentina STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
- 8.6.1. Middle East and Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
  - 8.6.2.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
  - 8.6.3.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
  - 8.6.4.1. UAE STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
  - 8.6.5.1. Kuwait STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. BD
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. F. Hoffmann-La Roche Ltd
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Hologic Inc.
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. Abbott
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Cepheid (Danaher)
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Qiagen
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. OraSure Technologies, Inc.
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. Bio-Rad Laboratories, Inc.
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. bioMerieux SA
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. Thermo Fisher Scientific, Inc.
  - 9.4.10.1. Participant's Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Recent Developments/ Strategic Initiatives
- 9.4.11. Seegene Inc.
  - 9.4.11.1. Participant's Overview
  - 9.4.11.2. Financial Performance
  - 9.4.11.3. Product Benchmarking
  - 9.4.11.4. Recent Developments/ Strategic Initiatives
- 9.4.12. DiaSorin S.p.A
  - 9.4.12.1. Participant's Overview
  - 9.4.12.2. Financial Performance
  - 9.4.12.3. Product Benchmarking
  - 9.4.12.4. Recent Developments/ Strategic Initiatives

STD診断の市場規模、シェア、動向分析レポート：用途別、製品別、技術別、検査場所別、地域別、セグメント予測、2025年～2030年

STD Diagnostics Market Size, Share & Trends Analysis Report By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Product, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2025 - 2030

STD診断市場の成長と動向：

STD診断市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章 STD診断市場の変数、動向、範囲

第4章 STD診断市場：製品推定・動向分析

第5章 STD診断市場：用途の推定・動向分析

第6章 STD診断市場：技術推定・動向分析

第7章性感染症診断市場：検査場所の推定・動向分析

第8章性感染症診断市場：地域別推定・動向分析

第9章競合情勢

List of Tables

List of Figures

STD Diagnostics Market Growth & Trends:

STD Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. STD Diagnostics Market Variables, Trends, & Scope

Chapter 4. STD Diagnostics Market: Product Estimates & Trend Analysis

Chapter 5. STD Diagnostics Market: Application Estimates & Trend Analysis

Chapter 6. STD Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 7. STD Diagnostics Market: Location of Testing Estimates & Trend Analysis

Chapter 8. STD Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

STD診断の市場規模、シェア、動向分析レポート：用途別、製品別、技術別、検査場所別、地域別、セグメント予測、2025年～2030年

STD Diagnostics Market Size, Share & Trends Analysis Report By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Product, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2025 - 2030

STD診断市場の成長と動向：

STD診断市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 STD診断市場の変数、動向、範囲

第4章 STD診断市場：製品推定・動向分析

第5章 STD診断市場：用途の推定・動向分析

第6章 STD診断市場：技術推定・動向分析

第7章 性感染症診断市場：検査場所の推定・動向分析

第8章 性感染症診断市場：地域別推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

STD Diagnostics Market Growth & Trends:

STD Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. STD Diagnostics Market Variables, Trends, & Scope

Chapter 4. STD Diagnostics Market: Product Estimates & Trend Analysis

Chapter 5. STD Diagnostics Market: Application Estimates & Trend Analysis

Chapter 6. STD Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 7. STD Diagnostics Market: Location of Testing Estimates & Trend Analysis

Chapter 8. STD Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第7章性感染症診断市場：検査場所の推定・動向分析

第8章性感染症診断市場：地域別推定・動向分析

第9章競合情勢